- Title: Subtitle
- Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)
- Creators
- Uri Greenbaum - Soroka Medical CenterHamza Hashmi - Medical University of South CarolinaMahmoud Elsawy - Dalhousie UniversitySoyoung Kim - Medical College of WisconsinAmy Moskop - Center for International Blood and Marrow Transplant ResearchFarrukh T. Awan - The University of Texas Southwestern Medical CenterUmar Farooq - University of IowaSiddhartha Ganguly - Houston MethodistPeiman Hematti - University of Wisconsin–MadisonMichael D. Jain - Moffitt Cancer CenterPartow Kebriaei - The University of Texas MD Anderson Cancer CenterFrederick L. Locke - Moffitt Cancer CenterElena Mead - Memorial Sloan Kettering Cancer CenterTaiga Nishihori - Moffitt Cancer CenterAmanda L. Olson - The University of Texas MD Anderson Cancer CenterMartina Pennisi - 17Memorial Medical Center, New Orleans, LAMiguel-Angel Perales - Memorial Sloan Kettering Cancer CenterPraveen Ramakrishnan GeethakumariRoni Shouval - Sheba Medical CenterElizabeth J. Shpall - The University of Texas MD Anderson Cancer CenterMargarida Magalhaes Magalhaes-Silverman - University of IowaChristopher Strouse - University of IowaCameron J. Turtle - Fred Hutch Cancer CenterAnusha Vallurupalli - University of PortlandKitsada Wudhikam - Chulalongkorn UniversityMarcelo C. Pasquini - Center for International Blood and Marrow Transplant ResearchSairah Ahmed - The University of Texas MD Anderson Cancer CenterMohamed Sorror - Fred Hutch Cancer Center
- Resource Type
- Abstract
- Publication Details
- Blood, Vol.140(Supplement 1), pp.4636-4638
- DOI
- 10.1182/blood-2022-169452
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Language
- English
- Date published
- 11/15/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984362343502771
Abstract
Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)
Blood, Vol.140(Supplement 1), pp.4636-4638
11/15/2022
DOI: 10.1182/blood-2022-169452
Details
Metrics
38 Record Views